Entry created on 1 July 2019 (Revision 1.0) Annotator: Rita Pancsa; Orsolya Kovács
Basic protein information
Accession Q13501
Common name p62
Gene SQSTM1
Organism Homo sapiens
Uniprot name Sequestosome-1
Basic LLPS information
Organelle inclusion body; p62 body
Type of experimental evidence
Protein region(s) mediating LLPS
3
-
102
PB1 domain (oligomerization)
389
-
440
UBA (polyUbi chain binding)
Based on the experimental results of the following publication: 29507397
Molecular features viewer
PDB structures
Extended LLPS information
Functional description
During the autophagy of misfolded, ubiquitinated proteins, referred to as aggrephagy, substrate proteins are clustered into larger structures in a SQSTM1/p62-dependent manner before they are sequestered by phagophores, the precursors to autophagosomes (PMID:29929426). SQSTM1/p62 and ubiquitinated proteins spontaneously phase separate into micrometer-sized clusters in vitro. p62 has an N-terminal PB1 domain (aa 3 – 102) and a C-terminal ubiquitin associated (UBA; aa 389 – 440) domain; the PB1 domain, which is required for p62 polymerization, and M404 in the UBA domain, which is essential for ubiquitin binding, are required for p62 body formation and autophagic degradation of p62 in vivo. Polyubiquitin chain-induced p62 phase separation was markedly impaired by p62-M404V and p62-ΔPB1. Also, recombinant p62 does not undergo phase separation in vitro, however, adding a K63 polyubiquitin chain to p62 induces p62 phase separation. These data suggest that p62 polymerization, as well as the interaction between polyubiquitin chains and p62, play critical roles in p62 phase separation (PMID:29507397). Aggrephagy is triggered by the accumulation of substrates with multiple ubiquitin chains and the process can be inhibited by active proteasomes (PMID:29929426).
Literature supporting the LLPS: 29507397, 29929426, 30287680, 29572488
Functional class of membraneless organelle: protective storage/reservoir
Binding partners (at biological protein concentrations)
1) K63 polyubiquitin chains (strictly required for LLPS)
Type of RNA(s) required/used for the LLPS at biological protein concentrations
RNA not required.
Molecular interaction types contributing to LLPS
linear oligomerization/self-association (PMID:29507397) multivalent domain-PTM interactions (PMID:29507397)
Determinants of phase separation and droplet properties
1) valence of the polyubiquitin chains
Membrane cluster No
Partner-dependent No
RNA-dependent No
PTM required Yes
Domain-motif interactions No
Discrete oligomerization Yes
Regulation and disease
Post-translational modifications affecting LLPS
Position Residue PTM Effect Reference Modifying enzyme Notes
Isoforms known to affect LLPS
Isoform Effect Reference
All known isoforms containing sequence changes in the LLPS region(s)
Position type Isoform names from UniProt
Disease mutations affecting LLPS
Mutation dbSNP Disease OMIM Effect Reference Notes
Experimental information
Experimental techniques applied to prove/investigate LLPS
In cultured cells, endogenous or ectopically expressed p62 forms cytoplasmic inclusion bodies (p62 bodies) (protein localization, particle size and count by microscopy). p62 bodies contain polyubiquitin chains and K63 polyubiquitin chains are preferentially recruited into p62 bodies (protein co-localization). In p62-GFP-expressing autophagy-defective Atg12−/− cells (genetic transformation, knock-out, overexpression, fusion protein), p62 bodies were spherical and could undergo fusion (morphology). Furthermore, FRAP experiments revealed that the fluorescent signal recovered after bleaching of p62 bodies. No phase separation occurs in a solution containing even as much as 120 µM recombinant mCherry-fused p62 in vitro (particle size and count by microscopy), only when adding a solution of K63 polyubiquitin chains. In the control reaction, which did not contain adenosine triphosphate (ATP) and therefore did not form K63 polyubiquitin chains, p62 phase separation was not induced. Thus, K63 polyubiquitin chains, but not monoubiquitin can induce p62 phase separation. When adding cytosol from p62−/− cells to recombinant mCherry-fused p62 in vitro LLPS occured (particle size and count by microscopy). However treatment of the p62−/− cytosol with UPS5, a deubiquitinating enzyme that removes polyubiquitin chains abolished in vitro LLPS. Polyubiquitinated proteins are segregated into p62 droplets (co-localization). Although both Ubx8 and Ubx6 could cause p62 phase separation, Ubx8 could induce p62 phase separation at a much lower concentration; moreover, when the concentrations of both p62 and Ub were fixed, Ubx8 induced much stronger p62 phase separation than Ubx6, thus the valence of the polyubiquitin chain is important for p62 LLPS. LC3 co-localized with p62 bodies in Atg12−/− cells (it could be recruited to the p62 bodies) in vivo and also showed similar behaviour in vitro. In vivo polyubiquitin chain-induced p62 phase separation (particle size and count by microscopy) was markedly impaired by mCherry-p62-M404V and mCherry-p62-ΔPB1 mutations. Phosphorylation of S403 promotes polyubiquitin chain-induced phase separation, p62 body formation, and autophagic degradation (particle size and count by microscopy). The M404T and G411S Paget’s disease of bone mutations both markedly impaired polyubiquitin chain-induced p62 phase separation (particle size and count by microscopy).
Experimental observations supporting the liquid material state of the condensate
dynamic movement/reorganization of molecules within the droplet (PMID:29507397) morphological traits (PMID:29507397)